
EAN 2019

Read the full Report (pdf)
European Academy of Neurology
29 June – 2 July 2019 Oslo, Norway
Featured articles

CONTENTS
Online First
Alzheimer’s Disease and other Dementias
A necessary shift of focus to the earlier stages of Alzheimer’s

Antipsychotics increase mortality regardless of comorbidity
Epilepsy
Neuroinflammatory pathways as biomarkers and treatment targets
Panel of inflammation-associated microRNAs as epilepsy biomarker
Clinical and cost effectiveness of levetiracetam vs valproate
Long-term effect of recurrent febrile seizures
Migraine
The role of neurogenic inflammation in migraine
Atogepant efficacious, safe, and well-tolerated for migraine prevention
Short- and long-term efficacy of erenumab in hard-to-treat patients

Fremanezumab results of the FOCUS study

Galcanezumab reduces healthcare resource utilisation
Lasmiditan in migraine patients with CV risk factors
Factors influencing choice of prophylactic migraine therapy
Multiple Sclerosis
Treating MS from disease onset

Long-term effects of established treatments
Randomised and observational studies comparing treatments
